Skip to content
MRI The Appy | Tazo or Cefepime episode artwork

Nov 4, 2023 7 min

MRI The Appy | Tazo or Cefepime

from JournalFeed

The JournalFeed podcast for the week of Oct 30 Nov 3, 2023. These are summaries from just 2 of the 5 article we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member. Tuesday Spoon Feed: After a non-diagnostic screening ultrasound for appendicitis, a rapid-MRI has high clinical accuracy in establishing the appropriate diagnosis (appendicitis or not) in a pediatric patient population. Friday Spoon Feed: In this randomized control trial (RCT) of patients receiving cefepime or piperacillin-tazobactam, there was no difference in risk of acute kidney injury (AKI) between the two groups. However, those who received cefepime were more likely to have neurologic side effects.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

MRI The Appy | Tazo or Cefepime

0:00 7:12

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of JournalFeed?

This episode is 7 minutes long.

When was this JournalFeed episode published?

This episode was published on November 4, 2023.

Can I download this JournalFeed episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.